The Use of Enzyme Inhibitors in Drug Discovery: Current Strategies and Future Prospects

Q4 Pharmacology, Toxicology and Pharmaceutics Current Enzyme Inhibition Pub Date : 2023-07-31 DOI:10.2174/1573408019666230731113105
Kuldeep Singh, J. Gupta, Devendra Pathak, Shivendra Kumar
{"title":"The Use of Enzyme Inhibitors in Drug Discovery: Current Strategies and Future Prospects","authors":"Kuldeep Singh, J. Gupta, Devendra Pathak, Shivendra Kumar","doi":"10.2174/1573408019666230731113105","DOIUrl":null,"url":null,"abstract":"\n\n: Enzyme inhibitors are an important therapeutic agent in drug discovery, as they can be used\nto manipulate biochemical pathways to treat a wide range of diseases. Current strategies for enzyme inhibition involve the use of small molecule inhibitors, natural products, or peptide-based inhibitors. These inhibitors can be used to target and modulate the activity of enzymes, which in turn can affect the\nprogression of a particular disease. The future of enzyme inhibitor-based drug discovery lies in the development of more selective and potent inhibitors, as well as the ability to target enzymes that are involved in multiple pathways. Additionally, there is significant potential for the use of enzyme inhibitors\nin combination with other therapeutic strategies, such as gene therapy. Finally, the development of novel computational strategies for the design and optimization of enzyme inhibitor-based drugs is an exciting area of research. Such strategies could lead to the discovery of new and more effective inhibitors,\nwhich would facilitate the development of improved treatments for a variety of diseases. Hence, this review focuses on some techniques for the discovery of enzyme inhibitors and their applications as various therapeutic agents.\n","PeriodicalId":35405,"journal":{"name":"Current Enzyme Inhibition","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2023-07-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current Enzyme Inhibition","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2174/1573408019666230731113105","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Pharmacology, Toxicology and Pharmaceutics","Score":null,"Total":0}
引用次数: 0

Abstract

: Enzyme inhibitors are an important therapeutic agent in drug discovery, as they can be used to manipulate biochemical pathways to treat a wide range of diseases. Current strategies for enzyme inhibition involve the use of small molecule inhibitors, natural products, or peptide-based inhibitors. These inhibitors can be used to target and modulate the activity of enzymes, which in turn can affect the progression of a particular disease. The future of enzyme inhibitor-based drug discovery lies in the development of more selective and potent inhibitors, as well as the ability to target enzymes that are involved in multiple pathways. Additionally, there is significant potential for the use of enzyme inhibitors in combination with other therapeutic strategies, such as gene therapy. Finally, the development of novel computational strategies for the design and optimization of enzyme inhibitor-based drugs is an exciting area of research. Such strategies could lead to the discovery of new and more effective inhibitors, which would facilitate the development of improved treatments for a variety of diseases. Hence, this review focuses on some techniques for the discovery of enzyme inhibitors and their applications as various therapeutic agents.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
酶抑制剂在药物发现中的应用:当前策略和未来展望
:酶抑制剂是药物发现中的一种重要治疗剂,因为它们可以用来操纵生物化学途径来治疗各种疾病。目前的酶抑制策略包括使用小分子抑制剂、天然产物或基于肽的抑制剂。这些抑制剂可用于靶向和调节酶的活性,从而影响特定疾病的进展。基于酶抑制剂的药物发现的未来在于开发更具选择性和效力的抑制剂,以及靶向参与多种途径的酶的能力。此外,酶抑制剂与其他治疗策略(如基因治疗)相结合也有很大的潜力。最后,开发新的计算策略来设计和优化基于酶抑制剂的药物是一个令人兴奋的研究领域。这些策略可能会发现新的、更有效的抑制剂,这将有助于开发各种疾病的改进治疗方法。因此,本文综述了酶抑制剂的发现技术及其作为各种治疗剂的应用。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Current Enzyme Inhibition
Current Enzyme Inhibition Pharmacology, Toxicology and Pharmaceutics-Drug Discovery
CiteScore
1.30
自引率
0.00%
发文量
30
期刊介绍: Current Enzyme Inhibition aims to publish all the latest and outstanding developments in enzyme inhibition studies with regards to the mechanisms of inhibitory processes of enzymes, recognition of active sites, and the discovery of agonists and antagonists, leading to the design and development of new drugs of significant therapeutic value. Each issue contains a series of timely, in-depth reviews written by leaders in the field, covering a range of enzymes that can be exploited for drug development. Current Enzyme Inhibition is an essential journal for every pharmaceutical and medicinal chemist who wishes to have up-to-date knowledge about each and every development in the study of enzyme inhibition.
期刊最新文献
Apocynaceae as a Potential Source for Acetylcholinesterase Inhibition in Symptomatic Regulation and Management of Alzheimer's Disease Inhibition of Perforin: A Potential Therapeutic Approach against Human Ailments Molecular Docking as a Method to Identify Prospective Compounds from Ocimum sanctum with Anti-Candidal Properties Design of Cyclobut-3-Ene-1,2 Dione Derivatives as Anti-tubercular Agents Enzyme Inhibition in Managing Cardiovascular Diseases
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1